Latest pharma updates on PharmaThisWeek

NEC, JFCR & Taiho to Develop Shared-Neoantigen Cancer Vaccines

NEC, together with the Japan Cancer Research Institute (JFCR) and Taiho Pharmaceutical, publicized a partnership to crea...

Read Full Story
FDA Approves Otsuka’s Voyxact for IgA Nephropathy (IgAN)

Otsuka's monoclonal antibody Voyxact has received FDA approval for the treatment of primary IgA nephropathy (IgAN) i...

Read Full Story
FDA Approves Durvalumab (Imfinzi) + FLOT Regimen for Resectable Gastric & GEJ Cancer

The U.S. FDA has given the green light to AstraZeneca’s durvalumab (Imfinzi) in combination with the FLOT chemothe...

Read Full Story
FDA Approves Novartis Gene Therapy Itvisma for Spinal Muscular Atrophy (SMA)

The U.S. FDA has granted Novartis' gene therapy Itvisma approval for the treatment of spinal muscular atrophy (SMA)...

Read Full Story
EMA CHMP Recommends 10 New Medicines for Approval

During its meeting from November 10 to 13 in the year 2025, the EMA-CHMP gave out a positive opinion which proposed the...

Read Full Story

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.